HPV Vaccination Recommendation for Young Males Could Lower Cancer Rates in Alabama

Why it matters locally: The new federal recommendation for routine HPV vaccination in young males directly impacts Alabama's public health landscape. With a population of over 5 million, Alabama faces its share of HPV-related cancers. Increased vaccination rates among young males can significantly reduce the incidence of these cancers and genital warts, ultimately lowering healthcare costs for individuals and the state. Additionally, it can lead to a healthier population and improve overall quality of life, especially in communities with limited access to healthcare.

---

A federal advisory committee on Thursday recommended routine Human Papillomavirus (HPV) vaccination for males aged 11 and 12. The Advisory Committee on Immunization Practices (ACIP), a group of medical and public health experts that advises the Centers for Disease Control and Prevention (CDC), approved the recommendation. The recommendation specifically calls for a three-dose schedule of HPV4, a vaccine designed to protect against Human Papillomavirus. The ACIP provides recommendations to the CDC, which then issues official guidelines to healthcare providers. The new guidelines will be made available to the public by the CDC in the future. HPV is a common virus that can cause several types of cancer later in life as well as genital warts. According to the CDC, about 80 million Americans are currently infected with HPV, and about 14 million people become newly infected each year.